International Biotechnology Trust’s Axsome Therapeutics AXSM Stock Holding History

International Biotechnology Trust’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.07M	Hold	58,300	–	–	1.37%	22
2023 Q2	$4.19M	Buy	+58,300	New	+$4.3M	1.27%	25
2022 Q4	–	Sell	-14,000	Closed	-$625K	–	64
2022 Q3	$625K	Buy	14,000 +13,465	+2,517%	+$673K	0.2%	57
2022 Q2	$14K	Sell	535 -13,465	-96%	-$426K	0.15%	72
2022 Q1	$5.4M	Buy	+14,000	New	+$434K	1.22%	28
2021 Q4	–	Sell	-14,000	Closed	-$461K	–	75
2021 Q3	$461K	Hold	14,000	–	–	0.11%	60
2021 Q2	$944K	Hold	14,000	–	–	0.25%	52
2021 Q1	$793K	Hold	14,000	–	–	0.21%	51
2020 Q4	$1.14M	Buy	+14,000	New	+$1.05M	0.31%	40

Other funds holding AXSM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Biotechnology Trust's AXSM Position: Q3 2023 in Review

International Biotechnology Trust held its Axsome Therapeutics (AXSM) position steady in Q3 2023 at 58,300 shares worth $4.07M. The position accounts for 1.37% of the portfolio, ranked #22.

International Biotechnology Trust first reported a position in AXSM in Q4 2020 and has held it in 9 quarters since. The position peaked at $5.4M in Q1 2022. 226 funds tracked by Wall St. Rank hold AXSM as of Q3 2023.

International Biotechnology Trust held 58,300 shares of Axsome Therapeutics worth $4.07M as of Q3 2023.
International Biotechnology Trust left its Axsome Therapeutics share count unchanged in Q3 2023.
Axsome Therapeutics made up 1.37% of International Biotechnology Trust's portfolio in Q3 2023, its #22 holding.
International Biotechnology Trust first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 9 quarters since.
International Biotechnology Trust's Axsome Therapeutics position peaked at $5.4M in Q1 2022.
226 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.